Cannabis is listed as a narcotic under Schedule I of the Law on Procedures for Legal Trade in Narcotic and Psychotropic Substances and Medicines (Narcotics Act). This includes cannabis resin, oil, extracts and tinctures of cannabis as well as leaves. The list of controlled substances is included in Law on the procedure for entry into force and application of the Criminal Code.
This report provides a detailed overview of Latvia’s regulatory framework for CBD and cannabis, as well as other minor cannabinoids, covering all policy areas from cultivation and extracts to finished products and import/export.
Reasons to buy
A CannIntelligence regulatory report will provide you with:
- A clear and detailed understanding of current regulatory requirements affecting this sector in a specific jurisdiction, enabling you to be confident your business and your products are compliant.
- The ability to plan ahead for specific regulatory changes.
- Strategic understanding of the policy climate within the jurisdiction, enabling you to forecast how it might affect business development.
- Sources of further information, for example, links to full texts of legislation and contact details for relevant government offices.
Table of contents
- Executive summary
- Hemp plant
- Extracts and synthetics
- Finished products containing CBD and extracts
- Import and export requirements
- Minor cannabinoids
- Medical cannabis
- Recreational cannabis
- Relevant laws
- Relevant bodies
Our research is completely independent and original. It is conducted by CannIntelligence’s multilingual legal analysis team, all specialists in this sector, and goes through a rigorous review and editing process before publication. Research draws on multiple sources, including: online and offline resources and data, specialist legal software, our own extensive databases and report archives, interviews with key stakeholders and government officials, and collaboration with local legal firms and on-the-ground professionals in the jurisdictions covered.